ArticlePharmaceuticals (Basel, Switzerland)2021

A Radiobrominated Tyrosine Kinase Inhibitor for EGFR with L858R/T790M Mutations in Lung Carcinoma.

Muammar Fawwaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.